CARLSBAD, Calif., Feb. 20, 2014 /PRNewswire/ -- Patriot
Scientific Corporation (OTCBB: PTSC) today announced that the
United States International Trade Commission (ITC) has issued a
notice affirming the Administrative Law Judge's September 6, 2013 Initial Determination (ID) in
regards to Patriot's US 5,809,336 ('336) patent. An
Investigation had been undertaken by the ITC in which Patriot and
other complainants alleged violations of Section 337 of the Tariff
Act, seeking importation bans against multiple respondents for
certain wireless consumer electronics devices marketed for sale in
the United States. The ITC reaffirmed that it found no
violation of Section 337 in the aforementioned investigation.
"We are disappointed the ITC has upheld its previous finding in
regards to the '336 patent," stated Cliff
Flowers, Patriot's Interim Chief Executive Officer.
"Several of our shareholders question how our October 2013 victory against HTC in U.S. District
Court for the Northern District of California over the same '336 patent,
reconciles with the ITC's position. Simply stated, we believe
the District Court got it right, and the ITC got it wrong. We
are evaluating our options with the ITC."
Respondents who remained subject to the ITC Investigation
included Barnes & Noble Inc., Garmin Ltd., HTC Corporation,
Huawei Technologies Co. Ltd., LG Electronics, Nintendo Co. Ltd.,
Novatel Wireless Inc., Samsung Electronics Co. Ltd., and ZTE
Corporation. Parallel proceedings in the U.S. District Court for
the Northern District of California alleging infringement of Patriot's
'749, '890 and '336 patents against the remaining ITC Respondents,
excluding HTC, have been stayed pending resolution of the ITC
Investigation.
In October, Patriot announced that it had won its patent
infringement lawsuit against HTC Corporation in the U.S. District
Court for the Northern District of California. HTC was found
to infringe multiple claims of Patriot's '336 patent. The
'336 patent is one of several patents that are part of a larger
portfolio held by Patriot, known as the Moore Microprocessor Patent
Portfolio™.
About Patriot Scientific Corporation
Headquartered in Carlsbad,
California, Patriot Scientific Corporation is the co-owner
of the Moore Microprocessor Patent Portfolio. For more information
on PTSC, visit www.ptsc.com.
About the MMP Portfolio™
The MMP Portfolio includes US patents as well as their European
and Japanese counterparts, which cover techniques that enable
higher performance and lower cost designs essential to consumer and
commercial digital systems ranging from PCs, cell phones and
portable music players to communications infrastructure, medical
equipment and automobiles.
Safe Harbor Statement: Statements herein which are not purely
historical, including statements regarding Patriot Scientific
Corporation's intentions, hopes, beliefs, expectations, intentions,
representations, projections, plans or predictions of the future
are forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. The forward-looking
statements involve risks and uncertainties including, but not
limited to, the risk that the recently filed actions and litigation
strategy may not be successful and the risks and uncertainties
relating to the future of our MMP joint-venture. It is
important to note that the company's actual results could differ
materially from those in any such forward-looking statements.
Factors that could cause actual results to differ materially
include, but are not limited to, risks and uncertainties associated
with the effect of changing economic conditions, trends in the
products markets, variations in the company's cash flow, market
acceptance risks, patent litigation, technical development risks,
and seasonality. Our business could be affected by a number
of other factors, including the risk factors listed from time to
time in the company's SEC reports including, but not limited to,
the annual report on Form 10-K for the year ended May 31, 2013 and the quarterly report on Form
10-Q for the period ended November 30,
2013. The company cautions investors not to place undue
reliance on the forward-looking statements contained herein.
Patriot Scientific Corporation disclaims any obligation, and does
not undertake to update or revise any forward-looking statements
made herein.
Contact:
Patriot Investor Relations
ir@ptsc.com
760-547-2700 x-102
SOURCE Patriot Scientific Corporation